Minor cannabinoids: Biosynthesis, molecular pharmacology and potential therapeutic uses

KB Walsh, AE McKinney, AE Holmes - Frontiers in pharmacology, 2021‏ - frontiersin.org
The medicinal use of Cannabis sativa L. can be traced back thousands of years to ancient
China and Egypt. While marijuana has recently shown promise in managing chronic pain …

Phytocannabinoids: Exploring pharmacological profiles and their impact on therapeutical use

NM Blebea, AI Pricopie, RA Vlad, G Hancu - International Journal of …, 2024‏ - mdpi.com
Phytocannabinoids, a diverse group of naturally occurring compounds extracted from the
Cannabis plant, have attracted interest due to their potential pharmacological effects and …

Cannabis, cannabinoids and cannabis-based medicines in cancer care

DI Abrams - Integrative cancer therapies, 2022‏ - journals.sagepub.com
As medical cannabis becomes legal in more states, cancer patients are increasingly
interested in the potential utility of the ancient botanical in their treatment regimen. Although …

[HTML][HTML] Cannabinol: history, syntheses, and biological profile of the greatest “minor” cannabinoid

C Maioli, D Mattoteia, HIM Amin, A Minassi… - Plants, 2022‏ - mdpi.com
Cannabis (Cannabis sativa L.) is an outstanding source of bioactive natural products, with
more than 150 different phytocannabinoids isolated throughout the decades; however …

The safety and comparative effectiveness of non-psychoactive cannabinoid formulations for the improvement of sleep: A double-blinded, randomized controlled trial

JL Saleska, C Bryant, A Kolobaric… - Journal of the …, 2024‏ - Taylor & Francis
Background Clinical evidence on the use of cannabidiol (CBD) for sleep remains limited.
Even fewer studies have tested the comparative effectiveness of cannabinoid formulations …

Cannabinoids, insomnia, and other sleep disorders

I Lavender, IS McGregor, A Suraev, RR Grunstein… - Chest, 2022‏ - Elsevier
Sleep disturbances are often cited as a primary reason for medicinal cannabis use, and
there is increasing clinical interest in the therapeutic potential of cannabinoids in treating …

[HTML][HTML] A randomized, double-blind, placebo-controlled decentralized trial to assess sleep, health outcomes, and overall well-being in healthy adults reporting …

A Kolobaric, SJ Hewlings, C Bryant, CS Colwell… - Nutrients, 2023‏ - mdpi.com
Inadequate sleep is a global health concern. Sleep is multidimensional and complex; new
multi-ingredient agents are needed. This study assessed the comparative effects of two multi …

[HTML][HTML] Minor phytocannabinoids: A misleading name but a promising opportunity for biomedical research

D Caprioglio, HIM Amin, O Taglialatela-Scafati… - Biomolecules, 2022‏ - mdpi.com
Despite the very large number of phytocannabinoids isolated from Cannabis (Cannabis
sativa L.), bioactivity studies have long remained focused on the so called “Big Four”[Δ9 …

Phytocannabinoids for the Treatment of Neuropathic Pain: A Sco** Review of Randomised Controlled Trials Published Between 2012 and 2023

M Lewis, S Baroutian, SM Hanning - Current Pain and Headache Reports, 2024‏ - Springer
Abstract Purpose of Review Neuropathic pain (NP) remains a challenge to treat, with 50% of
patients experiencing limited efficacy from current treatments. Medicinal cannabis, which …